OBJECTIVE: To investigate whether higher fasting serum glucose levels in cognitively normal, nondiabetic adults were associated with lower regional cerebral metabolic rate for glucose (rCMRgl) in brain regions preferentially affected by Alzheimer disease (AD). METHODS: This is a cross-sectional study of 124 cognitively normal persons aged 64 ± 6 years with a first-degree family history of AD, including 61 APOEε4 noncarriers and 63 carriers. An automated brain mapping algorithm characterized and compared correlations between higher fasting serum glucose levels and lower [(18)F]-fluorodeoxyglucose-PET rCMRgl measurements. RESULTS: As predicted, higher fasting serum glucose levels were significantly correlated with lower rCMRgl and were confined to the vicinity of brain regions preferentially affected by AD. A similar pattern of regional correlations occurred in the APOEε4 noncarriers and carriers. CONCLUSIONS: Higher fasting serum glucose levels in cognitively normal, nondiabetic adults may be associated with AD pathophysiology. Findings suggest that the risk imparted by higher serum glucose levels may be independent of APOEε4 status. This study raises additional questions about the role of the metabolic process in the predisposition to AD and supports the possibility of targeting these processes in presymptomatic AD trials.
OBJECTIVE: To investigate whether higher fasting serum glucose levels in cognitively normal, nondiabetic adults were associated with lower regional cerebral metabolic rate for glucose (rCMRgl) in brain regions preferentially affected by Alzheimer disease (AD). METHODS: This is a cross-sectional study of 124 cognitively normal persons aged 64 ± 6 years with a first-degree family history of AD, including 61 APOEε4 noncarriers and 63 carriers. An automated brain mapping algorithm characterized and compared correlations between higher fasting serum glucose levels and lower [(18)F]-fluorodeoxyglucose-PET rCMRgl measurements. RESULTS: As predicted, higher fasting serum glucose levels were significantly correlated with lower rCMRgl and were confined to the vicinity of brain regions preferentially affected by AD. A similar pattern of regional correlations occurred in the APOEε4 noncarriers and carriers. CONCLUSIONS: Higher fasting serum glucose levels in cognitively normal, nondiabetic adults may be associated with AD pathophysiology. Findings suggest that the risk imparted by higher serum glucose levels may be independent of APOEε4 status. This study raises additional questions about the role of the metabolic process in the predisposition to AD and supports the possibility of targeting these processes in presymptomatic AD trials.
Authors: Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy Journal: Proc Natl Acad Sci U S A Date: 2005-06-02 Impact factor: 11.205
Authors: E M Reiman; R D Lane; G L Ahern; G E Schwartz; R J Davidson; K J Friston; L S Yun; K Chen Journal: Am J Psychiatry Date: 1997-07 Impact factor: 18.112
Authors: D H Silverman; G W Small; C Y Chang; C S Lu; M A Kung De Aburto; W Chen; J Czernin; S I Rapoport; P Pietrini; G E Alexander; M B Schapiro; W J Jagust; J M Hoffman; K A Welsh-Bohmer; A Alavi; C M Clark; E Salmon; M J de Leon; R Mielke; J L Cummings; A P Kowell; S S Gambhir; C K Hoh; M E Phelps Journal: JAMA Date: 2001-11-07 Impact factor: 56.272
Authors: E M Reiman; R J Caselli; L S Yun; K Chen; D Bandy; S Minoshima; S N Thibodeau; D Osborne Journal: N Engl J Med Date: 1996-03-21 Impact factor: 91.245
Authors: Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: Rosebud O Roberts; David S Knopman; Ruth H Cha; Michelle M Mielke; V Shane Pankratz; Bradley F Boeve; Kejal Kantarci; Yonas E Geda; Clifford R Jack; Ronald C Petersen; Val J Lowe Journal: J Nucl Med Date: 2014-03-20 Impact factor: 10.057
Authors: Christopher M Marano; Clifford I Workman; Christopher H Lyman; Elisse Kramer; Carol R Hermann; Yilong Ma; Vijay Dhawan; Thomas Chaly; David Eidelberg; Gwenn S Smith Journal: Psychiatry Res Date: 2014-02-01 Impact factor: 3.222